ZNF883

gene
On this page

Summary

ZNF883 (zinc finger protein 883, HGNC:27271) is a protein-coding gene on chromosome 9q32, encoding Zinc finger protein 883 (P0CG24). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.

Source: NCBI Gene 169834 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 2 total
  • MANE Select transcript: NM_001101338

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27271
Approved symbolZNF883
Namezinc finger protein 883
Location9q32
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000228623
Ensembl biotypeprotein_coding
Entrez169834

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 7 protein_coding

ENST00000639662, ENST00000917919, ENST00000917920, ENST00000917921, ENST00000917922, ENST00000917923, ENST00000917924

RefSeq mRNA: 1 — MANE Select: NM_001101338 NM_001101338

Canonical transcript exons

ENST00000639662 — 5 exons

ExonStartEnd
ENSE00003805003112988129112999138
ENSE00003996463112999665112999814
ENSE00003996464113001994113002073
ENSE00003996465113011141113011227
ENSE00003996466113012150113012192

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 85.34.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.7246 / max 107.9373, expressed in 1016 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1020775.72461016

Top tissues by expression

137 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.34gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.66gold quality
thymusUBERON:000237083.26silver quality
cortical plateUBERON:000534383.08gold quality
cerebellar vermisUBERON:000472082.74gold quality
nucleus accumbensUBERON:000188280.98gold quality
caudate nucleusUBERON:000187380.29gold quality
putamenUBERON:000187480.07gold quality
spinal cordUBERON:000224079.18gold quality
C1 segment of cervical spinal cordUBERON:000646979.15gold quality
corpus callosumUBERON:000233678.88gold quality
ganglionic eminenceUBERON:000402378.36gold quality
ventricular zoneUBERON:000305378.17gold quality
primary visual cortexUBERON:000243677.90gold quality
Ammon’s hornUBERON:000195477.11gold quality
amygdalaUBERON:000187677.05gold quality
temporal lobeUBERON:000187176.90gold quality
prefrontal cortexUBERON:000045176.31gold quality
anterior cingulate cortexUBERON:000983576.22gold quality
substantia nigraUBERON:000203875.83gold quality
cerebral cortexUBERON:000095675.66gold quality
brainUBERON:000095575.54gold quality
frontal cortexUBERON:000187075.28gold quality
superior frontal gyrusUBERON:000266175.22gold quality
hypothalamusUBERON:000189875.05gold quality
dorsolateral prefrontal cortexUBERON:000983474.77gold quality
right frontal lobeUBERON:000281073.97gold quality
Brodmann (1909) area 9UBERON:001354073.74gold quality
cerebellar cortexUBERON:000212972.61gold quality
cerebellar hemisphereUBERON:000224572.50gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.99

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)

Protein

Protein identifiers

Zinc finger protein 883P0CG24 (reviewed: P0CG24)

All UniProt accessions (1): P0CG24

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_001094808* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050758Znf_C2H2-typeFamily

Pfam: PF00096, PF13465, PF13912

UniProt features (14 total): zinc finger region 13, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0CG24-F190.030.71

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 14 (showing top): GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS, chr9q32, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS, GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN, GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP, GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP, GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
transcription by RNA polymerase II1
DNA-templated transcription1
negative regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

76 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF883ENPP4Q9Y6X5581
ZNF883ATF7IPQ6VMQ6447
ZNF883TMEM231Q9H6L2321
ZNF883GTF2F1P35269295
ZNF883KCNJ9Q92806271
ZNF883GGCXP38435246
ZNF883SLC39A1Q9NY26224
ZNF883MBTPS2O43462203
ZNF883KCNJ3P48549202
ZNF883GABBR2O75899184
ZNF883KDRP35968171
ZNF883POLEQ07864165
ZNF883CNSTQ6PJW8137
ZNF883KRASP01116128
ZNF883ERASQ7Z444100

IntAct

5 interactions, top by confidence:

ABTypeScore
ZNF883CCDC125psi-mi:“MI:0915”(physical association)0.560
ZNF883ECE1psi-mi:“MI:0915”(physical association)0.370
ZNF883CCDC125psi-mi:“MI:0915”(physical association)0.000

BioGRID (1): ZNF883 (Two-hybrid)

ESM2 similar proteins: C9JN71, E9QAG8, O75820, P08043, P0CG24, P10751, P15620, P17017, P17039, P18716, P18718, P18732, P18735, P18736, P18744, P18746, P24399, Q14585, Q15072, Q28151, Q3KP31, Q3SYV7, Q3ZCT1, Q4R4C7, Q4VA44, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5RAM9, Q5RB30, Q5RDX1, Q5REI6, Q5RF70, Q5RFP4, Q60493, Q62513, Q62981, Q6AZW8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

2 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000218416 (9:113001884 T>G), RS1000307922 (9:113007048 G>A), RS1000438649 (9:113007270 T>C), RS1000611395 (9:113000073 C>G,T), RS1000786555 (9:113012678 G>A), RS1000855629 (9:113014146 T>C), RS1000938238 (9:113013527 C>T), RS1001446986 (9:113007705 C>A,T), RS1001605437 (9:113010716 G>A,T), RS1001944641 (9:113012307 C>A,T), RS1001957549 (9:113012640 CG>C,CGG,CGGGGGGGG), RS1001977947 (9:113005550 T>C,G), RS1002113988 (9:113005974 A>G), RS1002162126 (9:113001876 CATCTGTTTAGTACAGAA>C), RS1002205191 (9:113012179 C>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009302_6Antipsychotic drug-induced weight gain in schizophrenia5.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004567antipsychotic drug related weight gain

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

17 total (human), top 17 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation, increases methylation, increases mutagenesis2
Nickeldecreases expression2
Phenylmercuric Acetatedecreases expression, affects cotreatment2
dicrotophosdecreases expression1
aflatoxin B2increases methylation1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangaffects cotreatment, increases expression1
Sunitinibdecreases expression1
Acetaminophendecreases expression1
Cisplatinaffects cotreatment, increases expression1
Tretinoindecreases expression1
Propofolincreases expression1
Okadaic Aciddecreases expression1
Acrylamidedecreases expression1
Particulate Matterincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.